InBody Co

InBody Co CROIC

The Cash Return on Invested Capital (CROIC) of InBody Co (041830.KQ) as of Oct 25, 2026 is 8.92 %. In the previous year, Cash Return on Invested Capital (CROIC) was 7.47 % — a change of 19.40% (higher).

CROIC

8.92 %

YoY

19.40%

Last updated:

Cash Return on Invested Capital (CROIC) of InBody Co is 2025 8.92 % . Cash Return on Invested Capital (CROIC) of InBody Co was 2024 7.47 % . It decreases by 19.40% higher compared to the previous year.

The InBody Co CROIC history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

CROIC
Date
CROIC
Jan 1, 2018
-18.62 KRW
Jan 1, 2019
14.81 KRW
Jan 1, 2020
17.32 KRW
Jan 1, 2021
10.08 KRW
Jan 1, 2022
11.01 KRW
Jan 1, 2023
12.18 KRW
Jan 1, 2024
7.47 KRW
Jan 1, 2025
8.92 KRW
The InBody Co CROIC history
YEARCROICYoY
8.92 %+19.40%
7.47 %-38.66%
12.18 %+10.65%
11.01 %+9.26%
10.08 %-41.81%
17.32 %+16.90%
14.81 %-179.56%
-18.62 %-249.46%
12.46 %+16.93%
10.65 %+124.05%
4.75 %-67.78%
14.76 %—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Get Free API Key

InBody Co Stock analysis

What does InBody Co do? InBody Co., Ltd. generates revenue through the sale of body composition analyzers under the InBody and Lookin’Body brand names. The InBody series includes models such as InBody720, InBody520, InBody230, InBody R20, InBody S20, InBody S10, and InBody J10, while the Lookin’Body series offers Lookin’Body3.0 and Lookin’Body Basic for measuring proteins, minerals, fats, and moisture. The company also sells BMI measuring devices under the BSM brand. Products are distributed domestically and internationally to meet demand in both markets. The primary customers for InBody’s equipment are healthcare facilities, fitness centers, and wellness providers seeking accurate body composition data. The InBody series targets professional and clinical settings, whereas Lookin’Body products cater to general wellness and fitness applications. BSM devices serve as complementary tools for body mass index tracking in similar environments. InBody Co., Ltd. focuses on selling medical equipment directly to end-users and distributors, with no mention of third-party partnerships or additional revenue streams. The company’s product portfolio is designed to address diverse needs within the health and fitness industry, leveraging its established brand names for market penetration. InBody Co is one of the most popular companies on Eulerpool.

Frequently Asked Questions about InBody Co stock

Cash Return on Invested Capital (CROIC) of InBody Co is 8.92 % in 2025.

Cash Return on Invested Capital (CROIC) of InBody Co changed from 7.47 % to 8.92 %, representing a 19.40% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of Cash Return on Invested Capital (CROIC) InBody Co since 2006 – with annual values, charts, and detailed analysis.

CROIC measures the cash return generated on invested capital. Unlike ROIC, it uses free cash flow instead of accounting earnings, providing a purer profitability measure.

A 'good' varies by industry and company stage. On Eulerpool, you can compare Cash Return on Invested Capital (CROIC)'s InBody Co with sector peers and the industry average to assess whether it is attractive.

To evaluate Cash Return on Invested Capital (CROIC)'s, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for Cash Return on Invested Capital (CROIC).

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Get Free API Key

Profitability — InBody Co

ROEROAROCEROICAsset TurnoverInventory TurnoverReceivables TurnoverDays Sales OutstandingDays Inventory OutstandingDays Payable OutstandingCash Conversion CycleCROICGross Profit/AssetsFixed Asset TurnoverEquity TurnoverWorking Capital TurnoverPayables TurnoverCapital IntensityReceivables/RevenueInventory/RevenueEBIT/Assets

All Key Metrics — InBody Co